During these unprecedented times, Clark, Perdue, & List Co, LPA is here to fully support your needs in a timely and safe manner. COVID-19 should not affect your ability to investigate a personal injury case. We currently remain open and are still accepting new cases. With your safety top of mind, we are scheduling all meetings via telephone or video conference at this time.

Elmiron & Blindness

Clark Perdue is proud of its decades long of counsel relationship with Anapol Weiss.  The collaborative effort between our firms has proven effective time and again in the representation of our mutual clients. We are pleased to announce that Anapol Weiss’ Senior...
FDA Proposes Recall of Zantac

FDA Proposes Recall of Zantac

The Food and Drug Administration has requested drug manufacturers recall the popular heart burn medication, Zantac. This move comes as a continuing FDA investigation has found that Zantac, and other drugs with the active ingredient ranitidine, often contain...
Zantac Linked to Cancer Risk When Stored in High Heat

Zantac Linked to Cancer Risk When Stored in High Heat

In a previous post, we wrote about the FDA’s investigation into the heartburn medication, Zantac, and other drugs containing ranitidine. The problem is that ranitidine has been found to contain N-Nitrosodimethylamine (“NDMA”), a suspected cancer causing agent in...
Zantac Cancer Risk

Zantac Cancer Risk

Zantac, a popular heartburn medication, has been pulled from major retailers shelves because some of its ingredients may be linked to Zantac cancer risk.  The Food and Drug Administration (“FDA”) continues to investigate the Zantac cancer risk, noting that...

Taxotere Hair Loss MDL Ordered

The Judicial Panel on Multidistrict Litigation ordered consolidation of all Taxotere hair loss cases on October 2, 2016. The panel noted that nearly 90 cases, alleging permanent hair loss resulting for the use of the chemotherapy drug, Taxotere, have been filed...